课题基金 / 基金详情

项目摘要

项目成果

David A. Hafler的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本提案描述了临床神经科学家培训计划(CNSTP),这是耶鲁医学院神经病学住院医师的研究教育计划。该计划整合了医学院内大量创新和令人兴奋的合作研究机会,并选择了一组杰出的神经科学专业导师。这些导师是根据重要的研究成就、一贯的独立资助记录和在指导临床科学家方面的杰出记录来选择的。这群导师,结合耶鲁大学充满活力的神经科学社区,培养杰出临床医生的良好记录,丰富的核心设施和资源,使耶鲁大学CNSTP成为一个独特的项目,发展医生科学家的职业生涯。自2008年以来,该项目已经建立了培养神经内科住院医师职业发展奖励的良好记录。目前的应用利用了这些现有的优势,并通过一个执行委员会和正式的监督和评价将其制度化,并寻求国家开发计划署的资金来支持这些努力。
英文摘要
DESCRIPTION (provided by applicant): This proposal describes the Clinical Neuroscientist Training Program (CNSTP), the research education program for Neurology residents at the Yale School of Medicine. This program integrates the vast array of innovative and exciting collaborative research opportunities available within the School of Medicine with a select group of outstanding, dedicated mentors in neuroscience. These mentors were selected on the basis of significant research accomplishments, a consistent record of independent funding, and an exceptional track record in the mentoring of clinician scientists. This group of mentors, when combined with the vibrant neuroscience community at Yale, a track record of training distinguished clinicians, rich core facilities and resources, makes the CNSTP at Yale a unique program that develops the careers of physician-scientists. Since 2008, this program already has an established track record of nurturing careers of neurology residents towards career development awards. The present application leverages these existing strengths and institutionalizes them with an executive committee and formal oversight and evaluations, and seeks NINDS funding to buttress these efforts.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
  • 批准号:
    10346649
  • 项目类别:
  • 资助金额:
    $69.51万
  • 财政年份:
    2022
  • 负责人:
    David A. Hafler
  • 依托单位:
Targeting T cell dysfunction in glioblastoma: A proof-of-concept Phase 0/I trial of anti-TIGIT antibody AB154 in combination with anti-PD1 antibody AB122
  • 批准号:
    10573141
  • 项目类别:
  • 资助金额:
    $67.34万
  • 财政年份:
    2022
  • 负责人:
    David A. Hafler
  • 依托单位:
Systems Immune Profiling of Divergent Responses to Infection
  • 批准号:
    10265709
  • 项目类别:
  • 资助金额:
    $107.73万
  • 财政年份:
    2020
  • 负责人:
    David A. Hafler
  • 依托单位:
Systems Immune Profiling of Divergent Responses to Infection
  • 批准号:
    10205567
  • 项目类别:
  • 资助金额:
    $45.42万
  • 财政年份:
    2020
  • 负责人:
    David A. Hafler
  • 依托单位:
国内基金
海外基金
患者依从性与脑卒中后跌倒风险相关性及“Teach-Back ”护理干预效应研究
  • 批准号:
    2026JJ81464
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    叶婷
  • 依托单位:
基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
  • 批准号:
    2024KP61
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    余丹
  • 依托单位:
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
  • 批准号:
    51307073
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    25.0万元
  • 批准年份:
    2013
  • 负责人:
    郭兴龙
  • 依托单位: